Subsequently, these patients were categorized into four groups based on both BRAF mutational status and intra-tumor TLS (BRAFWTTLSHigh, BRAFWTTLSLow, BRAFMTTLSHigh, and BRAFMTTLSLow). The gene discussed is BRAF; the disease is neoplasm.